Literature DB >> 16762807

Periodic leg movements in sleep and periodic limb movement disorder: prevalence, clinical significance and treatment.

Magdolna Hornyak1, Bernd Feige, Dieter Riemann, Ulrich Voderholzer.   

Abstract

Periodic leg movements in sleep (PLMS) are a frequent finding in polysomnography. The prevalence of PLMS is estimated to be 4-11% in adults. In childhood, PLMS rarely occur although medical conditions like sleep apnea syndrome or neuropsychiatric disorders can lead to high rates of PLMS. In the elderly, PLMS are also common in subjects without sleep disturbances. In sleep studies, PLMS are found most frequently in restless legs syndrome (RLS) and often occur in narcolepsy, sleep apnea syndrome and REM sleep behavior disorder. Some patients with otherwise unexplained insomnia or hypersomnia reveal an elevated number of PLMS, a condition defined as periodic limb movement disorder (PLMD). PLMS were found also in various medical and neurological disorders that do not primarily affect sleep. A summary of these is presented. In sleep disorders related to dopaminergic dysfunction such as RLS, PLMS are considered to be a symptom of the disease. In other disorders like primary insomnia, the clinical relevance of PLMS is still being controversially discussed. Studies with findings both pro and contra are referred. To date, only a few studies have evaluated the efficacy of therapeutic substances in reducing PLMS in PLMD patients. Their results need to be confirmed in controlled randomized trials.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16762807     DOI: 10.1016/j.smrv.2005.12.003

Source DB:  PubMed          Journal:  Sleep Med Rev        ISSN: 1087-0792            Impact factor:   11.609


  69 in total

Review 1.  Restless legs syndrome: pathophysiology, clinical presentation and management.

Authors:  Claudia Trenkwalder; Walter Paulus
Journal:  Nat Rev Neurol       Date:  2010-06       Impact factor: 42.937

2.  Restless legs syndrome: diagnostic assessment and the advantages and risks of dopaminergic treatment.

Authors:  Birgit Högl; Walter Paulus; Peter Clarenbach; Claudia Trenkwalder
Journal:  J Neurol       Date:  2006-08       Impact factor: 4.849

Review 3.  Iron for restless legs syndrome.

Authors:  Lynn M Trotti; Srinivas Bhadriraju; Lorne A Becker
Journal:  Cochrane Database Syst Rev       Date:  2012-05-16

4.  Antidepressant and Antipsychotic Drugs.

Authors:  Andrew D Krystal
Journal:  Sleep Med Clin       Date:  2010-12-01

5.  Periodic limb movements in sleep exhibit a circadian rhythm that is maximal in the late evening/early night.

Authors:  Jeanne F Duffy; Alex S W Lowe; Edward J Silva; John W Winkelman
Journal:  Sleep Med       Date:  2010-11-18       Impact factor: 3.492

6.  Time-linked concurrence of sleep bruxism, periodic limb movements, and EEG arousals in sleep bruxers and healthy controls.

Authors:  Jacques van der Zaag; Machiel Naeije; Darrel J Wicks; Hans L Hamburger; Frank Lobbezoo
Journal:  Clin Oral Investig       Date:  2013-05-09       Impact factor: 3.573

7.  [Portable sleep monitoring in patients with disorders in falling asleep or maintaining sleep].

Authors:  I Fietze; K Nötzel; A Blau; M Glos; T Penzel
Journal:  Nervenarzt       Date:  2012-08       Impact factor: 1.214

8.  Periodic Limb Movements in Sleep are Associated with Greater Cognitive Decline in Older Men without Dementia.

Authors:  Yue Leng; Terri Blackwell; Katie L Stone; Tina D Hoang; Susan Redline; Kristine Yaffe
Journal:  Sleep       Date:  2016-10-01       Impact factor: 5.849

9.  Sleep complaints in the adult Brazilian population: a national survey based on screening questions.

Authors:  Lia Rita A Bittencourt; Rogerio Santos-Silva; Jose A Taddei; Monica L Andersen; Marco T de Mello; Sergio Tufik
Journal:  J Clin Sleep Med       Date:  2009-10-15       Impact factor: 4.062

10.  Ropinirole in restless legs syndrome and periodic limb movement disorder.

Authors:  Daniel Erichsen; Raffaelle Ferri; David Gozal
Journal:  Ther Clin Risk Manag       Date:  2010-04-15       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.